Table 3.

Most common (>20%) AEs

All AEsAGS-16M8F(Hyb)AGS-16C3F(CHO)
n = 26n = 34
Subjects with at least 1 event26 (100%)34 (100%)
Fatigue12 (46.2%)24 (70.6%)
Nausea7 (26.9%)19 (55.9%)
Dry eye17 (50.0%)
Decreased appetite15 (44.1%)
Vision blurred15 (44.1%)
Vomiting13 (38.2%)
Thrombocytopenia8 (30.8%)12 (35.3%)
Headache11 (32.4%)
Keratitis11 (32.4%)
Anemia10 (29.4%)
Constipation8 (30.8%)10 (29.4%)
Dyspnea7 (26.9%)10 (29.4%)
Pyrexia8 (23.5%)
Epistaxis7 (20.6%)
Infusion-related reaction7 (20.6%)
Edema peripheral7 (20.6%)